Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Assets (2016 - 2025)

Historic Current Assets for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $36.0 billion.

  • Sanofi's Current Assets fell 2082.34% to $36.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $36.0 billion, marking a year-over-year decrease of 2082.34%. This contributed to the annual value of $35.0 billion for FY2025, which is 2411.5% down from last year.
  • As of Q4 2025, Sanofi's Current Assets stood at $36.0 billion, which was down 2082.34% from $39.8 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Current Assets ranged from a high of $46.3 billion in Q1 2025 and a low of $30.3 billion during Q2 2022
  • In the last 5 years, Sanofi's Current Assets had a median value of $35.2 billion in 2021 and averaged $36.9 billion.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 288143.19% in 2021, then crashed by 2082.34% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Current Assets stood at $35.0 billion in 2021, then fell by 0.47% to $34.8 billion in 2022, then dropped by 5.18% to $33.0 billion in 2023, then soared by 37.91% to $45.5 billion in 2024, then dropped by 20.82% to $36.0 billion in 2025.
  • Its last three reported values are $36.0 billion in Q4 2025, $39.8 billion for Q3 2025, and $41.9 billion during Q2 2025.